CSF CA 15-3 in breast cancer-related leptomeningeal metastases

Author： Le Rhun Emilie Kramar Andrew Salingue Sophie Girot Marie Rodrigues Isabelle Mailliez Audrey Zairi Fahed Bakhache Edgar Robin Yves Taillibert Sophie Dubois François Bonneterre Jacques Chamberlain Marc

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.117, Iss.1, 2014-03, pp. : 117-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tumour marker CA15-3: possible uses in the routine management of breast cancer

By Tomlinson I.P.M. Whyman A. Barrett J.A. Kremer J.K.

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 899-902

Elsevier

Access to resources Recommend Favorite

Ca 15-3 in the follow-up of localised breast cancer - a prospective study

By Kokko R. Holli K. Hakama M.

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1189-1193

Elsevier

Access to resources Recommend Favorite

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

By Clarke Jennifer Pao William Wu Nian Miller Vincent Lassman Andrew

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 283-286

Springer Publishing Company

Access to resources Recommend Favorite

Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations

By Lee Soohyeon

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 809-817

Springer Publishing Company

Access to resources Recommend Favorite

Spinal Leptomeningeal Metastases from Prostate Cancer

By Deinsberger R. Regatschnig R. Kaiser B. Bankl H.

Journal of Neuro-Oncology, Vol. 76, Iss. 3, 2006-02 ,pp. : 293-297

Springer Publishing Company

Access to resources Recommend Favorite